VentriPoint Diagnostics (CVE:VPT) Trading Down 14.7% – Here’s What Happened

by · The Cerbat Gem

VentriPoint Diagnostics Ltd. (CVE:VPT – Get Free Report) shares fell 14.7% during trading on Tuesday . The company traded as low as C$0.15 and last traded at C$0.15. 266,015 shares were traded during mid-day trading, a decline of 10% from the average session volume of 294,051 shares. The stock had previously closed at C$0.17.

VentriPoint Diagnostics Trading Down 9.1 %

The company has a debt-to-equity ratio of -58.56, a current ratio of 0.28 and a quick ratio of 6.67. The stock has a 50 day moving average of C$0.11 and a 200 day moving average of C$0.13. The firm has a market cap of C$24.33 million, a P/E ratio of -4.63 and a beta of 0.39.

About VentriPoint Diagnostics

(Get Free Report)

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.

See Also